High-Dose Resveratrol Supplementation in Obese Men: An Investigator-Initiated, Randomized, Placebo-Controlled Clinical Trial of Substrate Metabolism, Insulin Sensitivity, and Body Composition

Obesity, diabetes, hypertension, and hyperlipidemia constitute risk factors for morbidity and premature mortality. Based on animal and in vitro studies, resveratrol reverts these risk factors via stimulation of silent mating type information regulation 2 homolog 1 (SIRT1), but data in human subjects...

Descripción completa

Detalles Bibliográficos
Autores principales: Poulsen, Morten M., Vestergaard, Poul F., Clasen, Berthil F., Radko, Yulia, Christensen, Lars P., Stødkilde-Jørgensen, Hans, Møller, Niels, Jessen, Niels, Pedersen, Steen B., Jørgensen, Jens Otto L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3609591/
https://www.ncbi.nlm.nih.gov/pubmed/23193181
http://dx.doi.org/10.2337/db12-0975

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3609591/
https://www.ncbi.nlm.nih.gov/pubmed/23193181
http://dx.doi.org/10.2337/db12-0975

Ejemplares similares